{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T03:52:04Z","timestamp":1774410724432,"version":"3.50.1"},"reference-count":27,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2009,5,1]],"date-time":"2009-05-01T00:00:00Z","timestamp":1241136000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European Journal of Cancer"],"published-print":{"date-parts":[[2009,5]]},"DOI":"10.1016\/j.ejca.2009.01.006","type":"journal-article","created":{"date-parts":[[2009,2,8]],"date-time":"2009-02-08T09:20:22Z","timestamp":1234084822000},"page":"1193-1200","source":"Crossref","is-referenced-by-count":15,"title":["Long-term morbidity of adjuvant whole abdominal radiotherapy (WART) or chemotherapy for early stage ovarian cancer"],"prefix":"10.1016","volume":"45","author":[{"given":"M.J.A.","family":"Engelen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.J.","family":"Snel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Schaapveld","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Pras","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.G.E.","family":"de Vries","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.A.","family":"Gietema","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.G.J.","family":"van der Zee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.H.B.","family":"Willemse","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejca.2009.01.006_bib1","doi-asserted-by":"crossref","first-page":"2519","DOI":"10.1056\/NEJMra041842","article-title":"Cancer of the ovary","volume":"351","author":"Cannistra","year":"2004","journal-title":"New Engl J Med"},{"key":"10.1016\/j.ejca.2009.01.006_bib2","first-page":"249","article-title":"The Princess Margaret Hospital study of ovarian cancer: stages I, II, and asymptomatic III presentations","volume":"63","author":"Dembo","year":"1979","journal-title":"Cancer Treat Rep"},{"key":"10.1016\/j.ejca.2009.01.006_bib3","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/0360-3016(92)90777-F","article-title":"Epithelial ovarian cancer: the role of radiotherapy","volume":"22","author":"Dembo","year":"1992","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ejca.2009.01.006_bib4","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/S1053-4296(00)80022-3","article-title":"Integrating radiation therapy in the curative management of ovarian cancer: current issues and future directions","volume":"10","author":"Cardenes","year":"2000","journal-title":"Semin Radiat Oncol"},{"key":"10.1016\/j.ejca.2009.01.006_bib5","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1136\/ijgc-00009577-200307000-00001","article-title":"Systematic review of adjuvant therapy for early stage (epithelial) ovarian cancer","volume":"13","author":"Winter-Roach","year":"2003","journal-title":"Int J Gynecol Cancer"},{"issue":"Suppl. 2","key":"10.1016\/j.ejca.2009.01.006_bib6","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1081\/CNV-200030115","article-title":"First-line therapy for ovarian carcinoma: what\u2019s next?","volume":"22","author":"Thigpen","year":"2004","journal-title":"Cancer Invest"},{"issue":"Suppl. 3","key":"10.1016\/j.ejca.2009.01.006_bib7","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1111\/j.1525-1438.2005.00444.x","article-title":"Standard treatment in advanced ovarian cancer in 2005: the state of the art","volume":"15","author":"Bookman","year":"2005","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.ejca.2009.01.006_bib8","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1093\/jnci\/95.2.113","article-title":"International Collaborative Ovarian Neoplasm trial 1 and Adjuvant ChemoTherapy in Ovarian Neoplasm trial: two parallel randomized phase III trials of adjuvant chemotherapy in patients with early-stage ovarian carcinoma","volume":"95","author":"Trimbos","year":"2003","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.ejca.2009.01.006_bib9","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1093\/jnci\/95.2.113","article-title":"Impact of adjuvant chemotherapy and surgical staging in early-stage ovarian carcinoma: European Organisation for Research and Treatment of Cancer-Adjuvant ChemoTherapy in Ovarian Neoplasm trial","volume":"95","author":"Trimbos","year":"2003","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.ejca.2009.01.006_bib10","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1093\/jnci\/95.2.125","article-title":"International Collaborative Ovarian Neoplasm trial 1: a randomized trial of adjuvant chemotherapy in women with early-stage ovarian cancer","volume":"95","author":"Colombo","year":"2003","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.ejca.2009.01.006_bib11","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/S0360-3016(02)02728-1","article-title":"Adjuvant whole abdominal radiotherapy in epithelial cancer of the ovary","volume":"53","author":"Hepp","year":"2002","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ejca.2009.01.006_bib12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1056\/NEJM199001043220101","article-title":"Leukemia following chemotherapy for ovarian cancer","volume":"322","author":"Kaldor","year":"1990","journal-title":"New Engl J Med"},{"key":"10.1016\/j.ejca.2009.01.006_bib13","first-page":"1564","article-title":"Second malignant neoplasms among long-term survivors of ovarian cancer","volume":"56","author":"Travis","year":"1996","journal-title":"Cancer Res"},{"key":"10.1016\/j.ejca.2009.01.006_bib14","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1200\/JCO.2000.18.8.1725","article-title":"Cardiovascular morbidity in long-term survivors of metastatic testicular cancer","volume":"18","author":"Meinardi","year":"2000","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ejca.2009.01.006_bib15","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1016\/j.ejca.2003.11.026","article-title":"Long-term survivors of ovarian malignancies after cisplatin-based chemotherapy; cardiovascular risk factors and signs of vascular damage","volume":"40","author":"de Vos","year":"2004","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ejca.2009.01.006_bib16","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/0167-8140(88)90201-0","article-title":"Total abdominal irradiation in stage I and II carcinoma of the ovary","volume":"11","author":"van Bunningen","year":"1988","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ejca.2009.01.006_bib17","unstructured":"DCTD NND. Cancer Therapy Evaluation Program, Common Terminology Criteria for Adverse Events, Version 3.0. 12.12.2003."},{"key":"10.1016\/j.ejca.2009.01.006_bib18","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1016\/j.ijrobp.2005.10.014","article-title":"Adverse event reporting and developments in radiation biology after normal tissue injury: International Atomic Energy Agency consultation","volume":"64","author":"Chen","year":"2006","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ejca.2009.01.006_bib19","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1002\/(SICI)1097-0258(19990330)18:6<695::AID-SIM60>3.0.CO;2-O","article-title":"Estimation of failure probabilities in the presence of competing risks: new representations of old estimators","volume":"18","author":"Gooley","year":"1999","journal-title":"Stat Med"},{"key":"10.1016\/j.ejca.2009.01.006_bib20","first-page":"521","article-title":"Is adjuvant radiotherapy in early stages (FIGO I\u2013II) of epithelial ovarian cancer a treatment of the past?","volume":"14","author":"Skirnisdottir","year":"2005","journal-title":"Oncol Rep"},{"key":"10.1016\/j.ejca.2009.01.006_bib21","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S0301-2115(96)02672-3","article-title":"Long-term follow-up after adjuvant chemotherapy in completely resected early stage ovarian carcinoma","volume":"72","author":"Raymond","year":"1997","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.ejca.2009.01.006_bib22","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.ygyno.2004.08.040","article-title":"Twenty-five year outcome of sequential abdominal radiotherapy and melphalan:implications for future management of epithelial carcinoma of the ovary","volume":"96","author":"Dusenbery","year":"2005","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ejca.2009.01.006_bib23","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1161\/01.HYP.0000252676.46043.18","article-title":"Prevalence, awareness, treatment, and control of hypertension among United States adults 1999\u20132004","volume":"49","author":"Ong","year":"2007","journal-title":"Hypertension"},{"key":"10.1016\/j.ejca.2009.01.006_bib24","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1016\/0360-3016(95)00262-W","article-title":"Why actuarial estimates should be used in reporting late normal-tissue effects of cancer treatment \u2026 now!","volume":"32","author":"Bentzen","year":"1995","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ejca.2009.01.006_bib25","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/S0305-7372(03)00117-8","article-title":"Acute and long-term toxicity following radiotherapy alone or in combination with chemotherapy for locally advanced cervical cancer","volume":"29","author":"Maduro","year":"2003","journal-title":"Cancer Treat Rev"},{"key":"10.1016\/j.ejca.2009.01.006_bib26","doi-asserted-by":"crossref","unstructured":"The International Collaborative Ovarian Neoplasm (ICON) Group. Paclitaxel plus carboplatin versus standard chemotherapy with either single-agent carboplatin or cyclophosphamide, doxorubicin, and cisplatin in women with ovarian cancer: the ICON3 randomised trial. Lancet 2002;360:505\u201315.","DOI":"10.1016\/S0140-6736(02)09738-6"},{"key":"10.1016\/j.ejca.2009.01.006_bib27","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/S0360-3016(03)00510-8","article-title":"High-dose whole abdominal and pelvic irradiation for treatment of ovarian carcinoma: long-term toxicity and outcomes","volume":"57","author":"Firat","year":"2003","journal-title":"Int J Radiat Oncol Biol Phys"}],"container-title":["European Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959804909000045?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959804909000045?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,2]],"date-time":"2019-08-02T14:11:54Z","timestamp":1564755114000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0959804909000045"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,5]]},"references-count":27,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2009,5]]}},"alternative-id":["S0959804909000045"],"URL":"https:\/\/doi.org\/10.1016\/j.ejca.2009.01.006","relation":{},"ISSN":["0959-8049"],"issn-type":[{"value":"0959-8049","type":"print"}],"subject":[],"published":{"date-parts":[[2009,5]]}}}